Melatonin increases the survival time of animals with untreated mammary tumours: Neuroendocrine stabilization

Molecular and Cellular Biochemistry

Volumn 278, Issue 1-2, 2005, Pages 15-20

  Saez, M C ^a   Barriga, C ^a   Garcia, J J ^a   Rodriguez, A B ^a   Masot, J ^a   Duran, E ^a   Ortega, E ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

DMBA; Mammary tumours; Melatonin; Rats

Indexed keywords

ADRENALIN; CARCINOGEN; CATECHOLAMINE; DIMETHYLBENZ[A]ANTHRACENE; MELATONIN; NORADRENALIN; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HOMEOSTASIS; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PINEAL BODY; RAT; RAT STRAIN; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CATECHOLAMINES; EPINEPHRINE; FEMALE; KILLER CELLS, NATURAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MELATONIN; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TUMOR BURDEN;

ANIMALIA;

EID: 26444513249     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-7755-9     Document Type: Article

References (32)

1. Cohen M, Lipman M, Chabner B: Role of the pineal gland in the aetiology and treatment of breast cancer. Lancet 2: 814-816, 1978 10.1016/ S0140-6736(78)92591-6
2. Tamarkin L, Danforth DN, Lichter A, DeMoss E, Cohen M, Chabner B, Lippman M: Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216: 1003-1005, 1982 7079745
3. Anisimov VN: The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 46: 221-234, 2003 12791421
4. Lissoni P, Paolorossi F, Tancini G, Ardizzoia A, Barni S, Brivio F, Maestroni GJ, Chilelli M: A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients. Br J Cancer 74: 1466-1468, 1996 8912546
5. Lissoni P: Is there a role for melatonin in supportive care? Support Care Cancer 10: 110-116, 2002 10.1007/s005200100281
6. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castroviejo D: A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 18: 1-11, 1995 7776173
7. Barriga C, Martin MI, Tabla R, Ortega E, Rodríguez AB: Circadian rhythm of melatonin, corticosterone and phagocytosis: Effect of stress. J Pineal Res 30: 180-187, 2001 10.1034/j.1600-079X.2001.300307.x
8. Currier NL, Sun LZ, Miller SC: Exogenous melatonin: Quantitative enhancement in vivo of cells mediating non-specific immunity. J Neuroimmunol 104: 101-108, 2000 10.1016/S0165-5728(99)00271-4
9. Blask DE, Pelletier DB, Hill SM, Lemus-Wilson A, Grosso DS, Wilson ST, Wise ME: Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 117: 526-532, 1991 10.1007/BF01613283
10. Loscher W, Mevissen M, Haussler B: Seasonal influence on 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions. Pharmacol Toxicol 81: 265-270, 1997 9444667
11. Kubatka P, Bojkova BM, Cikova-Kalicka K, Mnichova-Chamilova M, Adamekova E, Ahlers I, Ahlersova E, Cermakova M: Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats. Folia Biol (Praha) 47: 5-10, 2001
12. Aoyama H, Mori N, Mori W: Anti-glucocorticoid effects of melatonin on adult rats. Acta Pathol Jpn 37: 1143-1148, 1987 3661196
13. Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E: Interactions between serotoninergic and aminoacidergic pathways in the control of PRL secretion in prepubertal male rats. J Physiol Biochem 57: 237-244, 2001 11800286
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
15. Russo J, Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5: 187-200, 2000 10.1023/A:1026443305758
16. De Jonage-Canonico MB, Lenoir V, Martin A, Scholler R, Kerdelhue B: Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. Breast Cancer Res Treat 79: 365-377, 2003 10.1023/A:1024059824430
17. Saez MC, Barriga C, Garcia JJ, Rodríguez AB, Ortega E: Effect of the preventive-therapeutic administration of melatonin on mammary tumor-bearing animals. Mol Cell Biochem 268: 25-31, 2005 10.1007/ s11010-005-2994-3
18. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci USA 92: 3650-3657, 1995 7731959
19. Currier NL, Miller SC: Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span. J Altern Complement Med 7: 241-251, 2001 10.1089/107555301300328115
20. Karasek M, Kuzdak K, Cywinski J, Zylinska K, Smialowska A, Pluzanska A: Effect of melatonin administration in advanced breast cancer patients - preliminary report. Neuroendocrinol Lett 19: 15-19, 1998
21. Mcikova-Kalicka K, Bojkova B, Adamekova E, Mnichova-Chamilova M, Kubatka P, Ahlersova E, Ahlers I: Preventive effect of indomethacin and melatonin on 7,12-dimethybenz/a/anthracene-induced mammary carcinogenesis in female Sprague-Dawley rats. A preliminary report. Folia Biol (Praha) 47: 75-79, 2001
22. Ahlersova E, Ahlers I, Kubatka P, Bojkova B, Mocikova K, Gajdosova S, Onderkova HM: Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats. Folia Biol (Praha) 46: 69-72, 2000
23. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: A review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415-3443, 1985 3926298
24. Vonderhaar BK: Prolactin involvement in breast cancer. Endocr Relat Cancer 6: 389-404, 1999 10.1677/erc.0.0060389
25. Cheung SY, Yuen MT, Choi HL, Cheng HK, Huang Y, Chen S, Chan FL: An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats. Int J Oncol 22: 1383-1395, 2003 12739009
26. Vazquez SM, Pignataro O, Luthy IA: Alpha2-adrenergic effect on human breast cancer MCF-7 cells. Breast Cancer Res Treat 55: 41-49, 1999 10.1023/A:1006196308001
27. Drell TL 4th, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F: Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 80: 63-70, 2003 10.1023/A:1024491219366
28. Bartsch C, Bartsch H, Buchberger A, Stieglitz A, Effenberger-Klein A, Kruse-Jarres JD, Besenthal I, Rokos H, Mecke D: Serial transplants of DMBA-induced mammary tumors in Fischer rats as a model system for human breast cancer. VI. The role of different forms of tumor-associated stress for the regulation of pineal melatonin secretion. Oncology 56: 169-176, 1999 10.1159/000011960
29. Kishi A, Takamori Y, Ogawa K, Takano S, Tomita S, Tanigawa M, Niman M, Kishida T, Fujita S: Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol Immunother 50: 604-614, 2002 10.1007/s002620100228
30. Nannmark U, Basse P, Johansson BR, Kuppen P, Kjergaard J, Hokland M: Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals. Nat Immun 15: 78-86, 1996-1997
31. ThyagaRajan S, Madden KS, Stevens SY, Felten DL: Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumours. J Neuroimmunol 109: 95-104, 2000 10.1016/ S0165-5728(00)00305-2
32. Lissoni P, Barni S, Tancini G, Rovelli F, Ardizzoia A, Conti A, Maestroni GJ: A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients. Oncology 50: 399-402, 1993 8233281